Novo Nordisk CEO: '80% of Wegovy pill customers' have never taken a GLP-1 before
June 9, 2026
841
13
3
1.90%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
CNBC Television Episodes Around June 9, 2026
See what was published immediately before and after this episode.
9:13Now PlayingNovo Nordisk CEO: '80% of Wegovy pill customers' have never taken a GLP-1 before
YouTube Description
as posted by the channelAt the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss the launch of the Wegovy pill and how it became the best prescription drug launch in history.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.